Evaluation of Oxidative Stress and Inflammatory Biomarkers Pre and Post-Treatment in New Diagnosed Atherosclerotic Patients

References

• Balbay Y, Gagnon AI, Malhan S, Oksuz ME, Sutherland G, Dobrescu A, Villa G, Ertugrul G, and Habib M, et al.Modeling the burden of cardiovascular disease in Turkey. Anatol J Cardiol. 2018;20(4):235–40. doi:10.14744/AnatolJCardiol.2018.89106.
   PubMed Web of Science ®Google Scholar
• Frostegard J.Immunity, atherosclerosis and cardiovascular disease. BMC Med. 2013;11(1):117. doi:10.1186/1741-7015-11-117.
   PubMed Web of Science ®Google Scholar
• Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S . Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease. Circ Res. 2016;118(4):535–46. doi:10.1161/CIRCRESAHA.115.307611.
   PubMed Web of Science ®Google Scholar
• Garcia C, Blesso CN.Antioxidant properties of anthocyanins and their mechanism of action in atherosclerosis. Free Radic Biol Med. 2021;172:152–66. doi:10.1016/j.freeradbiomed.2021.05.040.
   PubMed Web of Science ®Google Scholar
• Paoletti R, Gotto AM Jr., Hajjar DP.Inflammation in atherosclerosis and implications for therapy. Circulation. 2004;109(23 Suppl 1):III20–6. doi:10.1161/01.CIR.0000131514.71167.2e.
   PubMed Web of Science ®Google Scholar
• Tabas I, Garcia-Cardena G, Owens GK.Recent insights into the cellular biology of atherosclerosis. J Cell Biol. 2015;209(1):13–22. doi:10.1083/jcb.201412052.
   PubMed Web of Science ®Google Scholar
• Gistera A, Hansson GK.The immunology of atherosclerosis. Nat Rev Nephrol. 2017;13(6):368–80. doi:10.1038/nrneph.2017.51.
   PubMed Web of Science ®Google Scholar
• Wu MY, Li CJ, Hou MF, Chu PY . New insights into the role of inflammation in the pathogenesis of atherosclerosis. Int J Mol Sci. 2017;18(10):2034. doi:10.3390/ijms18102034.
   PubMed Web of Science ®Google Scholar
• Mullenix PS, Andersen CA, Starnes BW.Atherosclerosis as inflammation. Ann Vasc Surg. 2005;19(1):130–38. doi:10.1007/s10016-004-0153-z.
   PubMed Web of Science ®Google Scholar
• Legein B, Temmerman L, Biessen EAL, Lutgens E . Inflammation and immune system interactions in atherosclerosis. Cell Mol Life Sci. 2013;70(20):3847–69. doi:10.1007/s00018-013-1289-1.
   PubMed Web of Science ®Google Scholar
• Kattoor AJ, Pothineni NVK, Palagiri D, Mehta JL . Oxidative stress in atherosclerosis. Curr Atheroscler Rep. 2017;19(11):42. doi:10.1007/s11883-017-0678-6.
   PubMed Web of Science ®Google Scholar
• Yang X, Li Y, Li Y, Ren X, Zhang X, Hu D, Gao Y, Xing Y, Shang H . Oxidative stress-mediated atherosclerosis: mechanisms and therapies. Front Physiol. 2017;8:600.
   PubMed Web of Science ®Google Scholar
• Poznyak AV, Grechko AV, Orekhova VA, Chegodaev YS, Wu WK, Chegodaev AN . Oxidative stress and antioxidants in atherosclerosis development and treatment. Biology (Basel). 2020;9(3),60 doi:10.3390/biology9030060.
   Google Scholar
• Husain K, Hernandez W, Ansari RA, Ferder L . Inflammation, oxidative stress and renin angiotensin system in atherosclerosis. World J Biol Chem. 2015;6(3):209–17. doi:10.4331/wjbc.v6.i3.209.
   PubMedGoogle Scholar
• Salmas RE, Gulhan MF, Durdagi S, Sahna E, Abdullah HI, Selamoglu Z . Effects of propolis, caffeic acid phenethyl ester, and pollen on renal injury in hypertensive rat: an experimental and theoretical approach. Cell Biochem Funct. 2017;35(6):304–14. doi:10.1002/cbf.3277.
   PubMed Web of Science ®Google Scholar
• Ekhteiari Salmas R, Durdagi S, Gulhan MF, Duruyurek M, Abdullah HI, Selamoglu Z . The effects of pollen, propolis, and caffeic acid phenethyl ester on tyrosine hydroxylase activity and total RNA levels in hypertensive rats caused by nitric oxide synthase inhibition: experimental, docking and molecular dynamic studies. J Biomol Struct Dyn. 2018;36(3):609–20. doi:10.1080/07391102.2017.1288660.
   PubMed Web of Science ®Google Scholar
• Talas ZS, Ozdemir I, Ciftci O, Cakir O, Gulhan MF, Pasaoglu OM . Role of propolis on biochemical parameters in kidney and heart tissues against l -NAME induced oxidative injury in rats. Clinical and Experimental Hypertension. 2014;36(7):492–96. doi:10.3109/10641963.2013.863322.
   PubMed Web of Science ®Google Scholar
• Talas ZS, Yurekli M.The effects of enalapril maleate and cold stress exposure on tyrosine hydroxylase activity in some rat tissues. Cell Biochem Funct. 2006;24(6):537–40. doi:10.1002/cbf.1256.
   PubMed Web of Science ®Google Scholar
• Schulze PC, Lee RT.Oxidative stress and atherosclerosis. Curr Atheroscler Rep. 2005;7(3):242–48. doi:10.1007/s11883-005-0013-5.
   PubMedGoogle Scholar
• Gogebakan A, Talas ZS, Ozdemir I, Sahna E . Role of propolis on tyrosine hydroxylase activity and blood pressure in nitric oxide synthase-inhibited hypertensive rats. Clin Exp Hypertens. 2012;34(6):424–28. doi:10.3109/10641963.2012.665542.
   PubMed Web of Science ®Google Scholar
• Yuan T, Yang T, Chen H, Fu D, Hu Y, Wang J, Yuan Q, Yu H, Xu W, Xie X . New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis. Redox Biol. 2019;20:247–60 doi:10.1016/j.redox.2018.09.025.
   PubMed Web of Science ®Google Scholar
• Martinez GJ, Celermajer DS, Patel S.The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation. Atherosclerosis. 2018;269:262–71. doi:10.1016/j.atherosclerosis.2017.12.027.
   PubMed Web of Science ®Google Scholar
• Erel O.A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem. 2004;37(4):277–85. doi:10.1016/j.clinbiochem.2003.11.015.
   PubMed Web of Science ®Google Scholar
• Erel O.A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38(12):1103–11. doi:10.1016/j.clinbiochem.2005.08.008.
   PubMed Web of Science ®Google Scholar
• Erel O.A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004;37(2):112–19. doi:10.1016/j.clinbiochem.2003.10.014.
   PubMed Web of Science ®Google Scholar
• Gur M, Aslan M, Yildiz A, Demirbag R, Yilmaz R, Selek S, Erel O, Ozdogru I . Paraoxonase and arylesterase activities in coronary artery disease. Eur J Clin Invest. 2006;36(11):779–87. doi:10.1111/j.1365-2362.2006.01727.x.
   PubMed Web of Science ®Google Scholar
• Erel O, Neselioglu S.A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem. 2014;47(18):326–32. doi:10.1016/j.clinbiochem.2014.09.026.
   PubMed Web of Science ®Google Scholar
• Guler EM, Gokce M, Bacaksiz A, Kocyigit A . Urotensin-II, oxidative stress, and inflammation increase in hypertensive and resistant hypertensive patients. Clin Exp Hypertens. 2021;43(3):211–16. doi:10.1080/10641963.2020.1847128.
   PubMed Web of Science ®Google Scholar
• Zhang S, Li L, Chen W, Xu S, Feng X, Zhang L . Natural products: the role and mechanism in low-density lipoprotein oxidation and atherosclerosis. Phytother Res. 2021;35(6):2945–67. doi:10.1002/ptr.7002.
   PubMed Web of Science ®Google Scholar
• den Hartigh LJ.Conjugated linoleic acid effects on cancer, obesity, and atherosclerosis: a review of pre-clinical and human trials with current perspectives. Nutrients. 2019;11(2):370. doi:10.3390/nu11020370.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Juanatey C, Llorca J, Amigo-Diaz E, Dierssen T, Martin J Gonzalez-Gay MA . High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum. 2007;57(6):1074–80. doi:10.1002/art.22884.
   PubMed Web of Science ®Google Scholar
• Ait-Oufella H, Taleb S, Mallat Z Tedgui A . Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol. 2011;31(5):969–79. doi:10.1161/ATVBAHA.110.207415.
   PubMed Web of Science ®Google Scholar
• Tousoulis D, Oikonomou E, Economou EK, Crea F Kaski JC . Inflammatory cytokines in atherosclerosis: current therapeutic approaches. Eur Heart J. 2016;37(22):1723–32. doi:10.1093/eurheartj/ehv759.
   PubMed Web of Science ®Google Scholar
• Chistiakov DA, Melnichenko AA, Grechko AV, Myasoedova VA Orekhov AN . Potential of anti-inflammatory agents for treatment of atherosclerosis. Exp Mol Pathol. 2018;104(2):114–24. doi:10.1016/j.yexmp.2018.01.008.
   PubMed Web of Science ®Google Scholar
• Lamb FS, Choi H, Miller MR Stark RJ . TNFalpha and reactive oxygen signaling in vascular smooth muscle cells in hypertension and atherosclerosis. Am J Hypertens. 2020;33(10):902–13. doi:10.1093/ajh/hpaa089.
   PubMed Web of Science ®Google Scholar
• Autieri MV.Pro- and anti-inflammatory cytokine networks in atherosclerosis. ISRN Vascular Medicine. 2012;2012:1–17. doi:10.5402/2012/987629.
   Google Scholar
• Rosenson RS.Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities. Atherosclerosis. 2004;173(1):1–12. doi:10.1016/S0021-9150(03)00239-9.
   PubMed Web of Science ®Google Scholar
• Gur M, Turkoglu C, Taskın A, Ucar H, Borekci A, Seker T, Gozukara MY, Kaypakli O, Akyol S, and Selek S, et al. Paraoxonase-1 activity and oxidative stress in patients with anterior ST elevation myocardial infarction undergoing primary percutaneous coronary intervention with and without no-reflow. Atherosclerosis. 2014;234(2):415–20. doi:10.1016/j.atherosclerosis.2014.03.005.
   PubMed Web of Science ®Google Scholar
• Turan T, Mentese U, Agac MT, Akyuz AR, Kul S, Aykan AC, Bektas H, Korkmaz L, Oztas Mentese S, Dursun I, et al. The relation between intensity and complexity of coronary artery lesion and oxidative stress in patients with acute coronary syndrome. Anatol J Cardiol. 2015;15(10):795–800. doi:10.5152/akd.2014.5761.
   PubMed Web of Science ®Google Scholar
• Pignatelli P, Menichelli D, Pastori D Violi F . Oxidative stress and cardiovascular disease: new insights. Kardiol Pol. 2018;76(4):713–22. doi:10.5603/KP.a2018.0071.
   PubMed Web of Science ®Google Scholar
• Aslan M, Kosecik M, Horoz M, Selek S, Celik H Erel O . Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia. Atherosclerosis. 2007;191(2):397–402. doi:10.1016/j.atherosclerosis.2006.04.007.
   PubMed Web of Science ®Google Scholar
• Ozdemir B, Gulhan MF, Sahna E Selamoglu Z . The investigation of antioxidant and anti-inflammatory potentials of apitherapeutic agents on heart tissues in nitric oxide synthase inhibited rats via Nω-nitro-L-arginine methyl ester. Clin Exp Hypertens. 2021;43(1):69–76. doi:10.1080/10641963.2020.1806294.
   PubMed Web of Science ®Google Scholar
• Ding J, Chen Q, Zhuang X, Feng Z, Xu L, Chen F . Low paraoxonase 1 arylesterase activity and high von willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery disease. Med Sci Monit. 2014;20:2421–29 doi:10.12659/MSM.890911.
   PubMed Web of Science ®Google Scholar
• Shenhar-Tsarfaty S, Waiskopf N, Ofek K, Shopin L, Usher S, Berliner S, Shapira I, Bornstein NM, Ritov Y Soreq H . Atherosclerosis and arteriosclerosis parameters in stroke patients associate with paraoxonase polymorphism and esterase activities. Eur J Neurol. 2013;20(6):891–98. doi:10.1111/ene.12074.
   PubMed Web of Science ®Google Scholar
• Gulhan MF, Ozdemir B, Selamoglu Z Sahna E . The effects of apitherapeutic agents on oxidative stress in serum metabolic parameters of hypertensive rats created by nitric oxide synthase inhibited. Sains Malaysiana. 2021;50(6):1745–54. doi:10.17576/jsm-2021-5006-20.
   Web of Science ®Google Scholar
• Meisinger C, Freuer D, Bub A Linseisen J . Association between inflammatory markers and serum paraoxonase and arylesterase activities in the general population: a cross-sectional study. Lipids Health Dis. 2021;20(1):81. doi:10.1186/s12944-021-01508-7.
   PubMed Web of Science ®Google Scholar
• Tang WH, Hartiala J, Fan Y, Wu Y, Stewart AFR, Erdmann J, Kathiresan S, Roberts R, McPherson R, Allayee H, et al. Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk. Arterioscler Thromb Vasc Biol. 2012;32(11):2803–12. doi:10.1161/ATVBAHA.112.253930.
   PubMed Web of Science ®Google Scholar
• Kotur-Stevuljevic J, Vekić J, Stefanović A, Zeljković A, Ninić A, Ivanišević J, Miljković M, Sopić M, Munjas J, Mihajlović M, et al. Paraoxonase 1 and atherosclerosis-related diseases. Biofactors. 2020;46(2):193–205. doi:10.1002/biof.1549.
   PubMed Web of Science ®Google Scholar